LYCIA THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 27 Oct 2025)
What this means for you
This application is over — abandoned 27 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90672001
- Mark type
- Stylized text
- Filed
- 26 Apr 2021
- Published for opposition
- 26 Jul 2022
- Abandoned
- 27 Oct 2025
- Attorney of record
- Connie Ellerbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations comprising small molecules and antibodies for degrading disease-causing cellular proteins for treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Biological preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Gene therapy products, namely, biological preparations for the treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Pharmaceutical preparations for use in gene therapy; Biological preparations for use in gene therapy; Viruses for therapeutic purposes, namely, for gene therapy and antivirals
Owner
- Lycia Therapeutics, Inc., South San Francisco, CA, US
- Lycia Therapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 27 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 27 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 02 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 May 2025 — SOU EXTENSION 5 GRANTED
- 30 Jan 2025 — SOU EXTENSION 5 FILED
- 01 May 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Aug 2024 — SOU EXTENSION 4 GRANTED
- 06 Aug 2024 — SOU EXTENSION 4 FILED
- 06 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 06 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Feb 2024 — SOU EXTENSION 3 GRANTED
- 02 Feb 2024 — SOU EXTENSION 3 FILED
- 02 Feb 2024 — SOU TEAS EXTENSION RECEIVED